2-tetradecylglycidic acid has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astbury, LD; Caterson, ID; Kerbey, AL; Plehwe, WE; Turtle, JR; Williams, PF | 1 |
| Dell'Italia, LJ; Durand, J; Forrest, C; Oparil, S; Shen, H; Urthaler, F; Wei, CC; Wolkowicz, PE | 1 |
2 other study(ies) available for 2-tetradecylglycidic acid and Body Weight
| Article | Year |
|---|---|
The effect of body weight and the fatty acid-oxidation inhibitor 2-tetradecylglycidic acid on pyruvate dehydrogenase complex activity in mouse heart.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Epoxy Compounds; Ethers, Cyclic; Fatty Acids; Heart; Insulin; Male; Mice; Mice, Inbred CBA; Myocardium; Obesity; Pyruvate Dehydrogenase Complex | 1984 |
2-Tetradecylglycidic acid, an inhibitor of carnitine palmitoyltransferase-1, induces myocardial hypertrophy via the AT1 receptor.
Topics: Animals; Body Weight; Cardiomegaly; Carnitine O-Palmitoyltransferase; Epoxy Compounds; Fatty Acids; Heart Rate; Hemodynamics; Hypoglycemic Agents; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 1999 |